RIPK1 and periventricular leukomalacia: Furthermore, NF-κBp65 activation in the mice with PVL not only increased NOX2 levels but also promoted FADD and RIPK1 expression, and these effects were reversed by BAY (NF-κB inhibitor) (Figure 5J).